Network origin in Anna Novotney-Barry first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA.
17
| Subsidiary | Pharmaceuticals: Major | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Anna Novotney-Barry via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| CELGENE | Biotechnology | Treasurer Director/Board Member | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Secretary | |
| GLYCOMIMETICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer Director/Board Member | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Founder Director/Board Member | |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Pharmaceuticals: Major | Founder Director/Board Member | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Founder Director/Board Member | |
| NEA 13 GP Ltd. | Director/Board Member | ||
| ZOSANO PHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| NEA 12 GP LLC | Corporate Officer/Principal | ||
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | Director/Board Member | |
| NEA 11 GP LLC | Corporate Officer/Principal | ||
| J.E.M. CAPITAL INC | Financial Conglomerates | Director/Board Member | |
| GALERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Components | Founder | |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Chief Executive Officer | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member | |
| Bethesda Research Laboratories, Inc. | Chief Executive Officer | ||
Cardioxyl Pharmaceuticals LLC
 Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Pharmaceuticals: Major | Director/Board Member | |
| Santa Clara University | College/University | Masters Business Admin | |
| SUPERNUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member | |
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member | |
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chairman | |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ECHO GLOBAL LOGISTICS, INC. | Trucking | Corporate Officer/Principal | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Closely, Inc.
 Closely, Inc. Miscellaneous Commercial ServicesCommercial Services Closely, Inc. provides mobile and web-based tools that help merchants promote their business and create loyal customers. It specializes in small business marketing, local marketing, SMB, SAAS startup. The company was founded by Karyn German and Perry R. Evans on December 3, 2009 and is headquartered in Denver, CO. | Miscellaneous Commercial Services | Director/Board Member | |
| Lafayette College | College/University | Undergraduate Degree |
Statistics
International
| United States | 48 |
| Bermuda | 2 |
| Hong Kong | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 34 |
| Commercial Services | 4 |
| Retail Trade | 3 |
| Finance | 3 |
| Consumer Services | 3 |
Operational
| Director/Board Member | 97 |
| Chairman | 38 |
| Corporate Officer/Principal | 30 |
| Independent Dir/Board Member | 24 |
| Founder | 21 |
Most connected contacts
| Insiders | |
|---|---|
| Michael Barrett | 49 |
| Gabriele Cerrone | 22 |
| Russell Medford | 21 |
| Christopher McGuigan | 17 |
| Joseph Patti | 14 |
| Mike A. Henos | 11 |
| Katherine Reynolds Kelly | 10 |
| Kabir Kumar Nath | 9 |
| John H. Vernachio | 7 |
| Uday Patel | 7 |
| Jeffrey Galik | 7 |
| P. Campisi | 6 |
| Russell H. Plumb | 6 |
| A. Keith Willard | 5 |
| Marc L. Preminger | 5 |
- Stock Market
- Insiders
- Anna Novotney-Barry
- Company connections
